Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/21/15 → 1/21/18 |
Funding
- Agility Clinical (WTX101-201 // WTX101-201)
- Wilson Therapeutics AB (WTX101-201 // WTX101-201)
WTX101-201: A Phase 2, Multi-centre, Open-label, Study to Evaluate the Efficacy and Safety of TWX101 Administered for 24 Weeks in Newly Diagnosed Wilson Disease Patients Aged 18 and Older
- Bega, Danny (PD/PI)
Project: Research project